New Questions Emerging Over Paxlovid’s Effectiveness Against COVID-19

The AP (5/9, Perrone) reports that as more physicians prescribe Pfizer’s Paxlovid for COVID-19, “new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug.” The drug “has become the...